2016
Differences in Active and Passive Smoking Exposures and Lung Cancer Incidence Between Veterans and Non-Veterans in the Women’s Health Initiative
Bastian LA, Gray KE, DeRycke E, Mirza S, Gierisch JM, Haskell SG, Magruder KM, Wakelee HA, Wang A, Ho GY, LaCroix AZ. Differences in Active and Passive Smoking Exposures and Lung Cancer Incidence Between Veterans and Non-Veterans in the Women’s Health Initiative. The Gerontologist 2016, 56: s102-s111. PMID: 26768384, PMCID: PMC5881614, DOI: 10.1093/geront/gnv664.Peer-Reviewed Original ResearchConceptsPassive smoking exposureWomen's Health InitiativeSmoking exposureLung cancer incidenceLung cancerWomen veteransHealth initiativesCancer incidenceHigh riskCox proportional hazards modelLung cancer incidence ratesOlder women veteransPassive tobacco exposureCancer incidence ratesProportional hazards modelHigh ratePostmenopausal womenPack yearsPassive smokingTobacco exposureProspective dataIncidence rateNon-VeteransTobacco useHazards model
1999
HORMONE REPLACEMENT THERAPY AND THE RISK OF COLORECTAL CANCER
Nanda K, Bastian L, Hasselblad V, Simel D. HORMONE REPLACEMENT THERAPY AND THE RISK OF COLORECTAL CANCER. Obstetrics And Gynecology 1999, 93: 880-888. DOI: 10.1097/00006250-199905001-00041.Peer-Reviewed Original ResearchHormone replacement therapyFatal colon cancerSummary relative riskRectal cancer incidenceHRT usersColon cancerColorectal cancerRelative riskReplacement therapyCancer incidenceAssociation of HRTUse of HRTRisk estimatesPostmenopausal HRT usersRecent HRT useRetrievable risk estimatesAdjusted risk estimatesMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language literatureTime of assessmentEstrogen usersHormone replacement therapy and the risk of colorectal cancer: a meta-analysis.
Nanda K, Bastian L, Hasselblad V, Simel D. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstetrics And Gynecology 1999, 93: 880-8. PMID: 10912438, DOI: 10.1016/s0029-7844(98)00424-4.Peer-Reviewed Original ResearchConceptsHormone replacement therapyFatal colon cancerSummary relative riskRectal cancer incidenceHRT usersColon cancerColorectal cancerRelative riskReplacement therapyCancer incidenceAssociation of HRTUse of HRTRisk estimatesPostmenopausal HRT usersRecent HRT useRetrievable risk estimatesAdjusted risk estimatesMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language literatureTime of assessmentEstrogen users
1998
Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis
Nanda K, Bastian L, Hasselblad V, Simel D. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Primary Care Update For OB/GYNS 1998, 5: 165. PMID: 10838309, DOI: 10.1016/s1068-607x(98)00064-x.Peer-Reviewed Original ResearchHormone replacement therapySummary relative riskRectal cancer incidenceHRT usersColon cancerReplacement therapyCancer incidenceRelative riskUse of HRTRisk estimatesPostmenopausal HRT usersRetrievable risk estimatesColorectal cancer incidenceAdjusted risk estimatesColon cancer mortalityRisk of deathMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language studiesTime of assessmentEstrogen usersHRT useBreast Cancer Practice Patterns at VA Hospitals: Implications for Future Research
Hynes D, Hines E, Bastian L. Breast Cancer Practice Patterns at VA Hospitals: Implications for Future Research. Cancer Treatment And Research 1998, 97: 149-158. PMID: 9711415, DOI: 10.1007/978-0-585-30498-4_11.Peer-Reviewed Original ResearchConceptsVA hospitalsHealth care servicesWomen veteransBreast cancerCancer-related admissionsWomen Veteran populationWomen's health care servicesBreast cancer careCancer incidence estimatesBreast cancer screeningCancer careCancer screeningCancer incidencePractice patternsIncidence estimatesFiscal year 1994General populationInpatient servicesVeteran populationTreatment servicesCare servicesFemale veteransHospitalVeteransWomen